Form 6-K NOVARTIS AG For: Mar 31

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. ORCL
7. USO
8. STZ
9. CRGY
10. AAPL

Go back to Form 6-K NOVARTIS AG For: Mar 31

Sandoz (NVS) Receives Positive EMA CHMP Opinion on Pregabalin as Epilepsy and GAD Treatment

April 24, 2015 7:53 AM EDT

On 23 April 2015, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Pregabalin Sandoz GmbH, intended for the treatment of epilepsy and generalized anxiety disorder. The applicant for this medicinal product is Sandoz GmbH, a unit of Novartis (NYSE:... More

Novartis (NVS) Tops Q1 EPS Views

April 23, 2015 9:22 AM EDT

Novartis (NYSE: NVS) reported Q1 EPS of $1.33, $0.23 better than the analyst estimate of $1.10. Revenue for the quarter came in at $11.9 billion versus the consensus estimate of $12.9 billion.

For total Group, Q1 divestments resulted in exceptional operating income gains totaling USD 12.8... More